2,4-pentanedione

2,4-pentanedione is a lipid of Fatty Acyls (FA) class. The related lipids are Butyrates.

Cross Reference

Introduction

To understand associated biological information of 2,4-pentanedione, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,4-pentanedione?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,4-pentanedione

PubChem Associated disorders and diseases

What pathways are associated with 2,4-pentanedione

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,4-pentanedione?

There are no associated biomedical information in the current reference collection.

What functions are associated with 2,4-pentanedione?

There are no associated biomedical information in the current reference collection.

What lipids are associated with 2,4-pentanedione?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 2,4-pentanedione?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,4-pentanedione?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,4-pentanedione

Download all related citations
Per page 10 20 50 100 | Total 1027
Authors Title Published Journal PubMed Link
Saad HA et al. Synthesis and analgesic activity of some new pyrazoles and triazoles bearing a 6,8-dibromo-2-methylquinazoline moiety. 2011 Molecules pmid:22157581
Iakovidis I et al. Copper and its complexes in medicine: a biochemical approach. 2011 Mol Biol Int pmid:22091409
Zhao Y et al. (1E,4Z,6E)-5-Hy-droxy-1,7-bis-(2-meth-oxy-phen-yl)-1,4,6-hepta-trien-3-one. 2011 Acta Crystallogr Sect E Struct Rep Online pmid:22090937
Mohamed SK et al. 2-Amino-4-phenyl-4H,10H-1,3,5-triazino[1,2-a]benzimidazol-3-ium chloride. 2011 Acta Crystallogr Sect E Struct Rep Online pmid:21754462
Ahmad R et al. 3-Acetyl-5-hy-droxy-2-methyl-anthra[1,2-b]furan-6,11-dione. 2011 Acta Crystallogr Sect E Struct Rep Online pmid:21754452
Wang FM (Acetyl-acetonato-κO,O')(2-bromo-4-chloro-6-{[2-(dimethyl-amino)-ethyl-imino]-meth-yl}phenolato-κN,N',O)oxidovanadium(IV). 2011 Acta Crystallogr Sect E Struct Rep Online pmid:21754355
Kumar M et al. Zinc complexes of Ttz(R,Me) with O and S donors reveal differences between Tp and Ttz ligands: acid stability and binding to H or an additional metal (Ttz(R,Me) = tris(3-R-5-methyl-1,2,4-triazolyl)borate; R = Ph, tBu). 2011 Dalton Trans pmid:21706096
Gasser G et al. Organometallic anticancer compounds. 2011 J. Med. Chem. pmid:21077686
Jacobsen JA et al. Identifying chelators for metalloprotein inhibitors using a fragment-based approach. 2011 J. Med. Chem. pmid:21189019
Frapper G et al. Mechanisms of the Knoevenagel hetero Diels-Alder sequence in multicomponent reactions to dihydropyrans: experimental and theoretical investigations into the role of water. 2011 Phys Chem Chem Phys pmid:21063611